Wachtell, Skadden Shape $11.4B Pfizer-Array Deal
Pfizer, led by Wachtell, unveiled plans Monday to buy Array BioPharma, advised by Skadden, in an $11.4 billion deal, as the pharmaceutical giant looks to complement its current cancer treatment offerings...To view the full article, register now.
Already a subscriber? Click here to view full article